Clinical Trial Update: A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating first-line treatment of squamous non-small cell lung cancer with gemcitabine-cisplatin chemotherapy plus necitumumab; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Necitumumab (necitumumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-27